Essai en cours de recrutement = ; Essai en cours = ; Financé par un membre IRDiRC = ; Membre d'un ERN =

Essai(s) clinique(s) national(aux)

ETATS-UNIS

Texas
IRVING

MOXIe: A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedreich's Ataxia - AT

Reata Pharmaceuticals

Plus de détails

ETATS-UNIS

Texas
IRVING

CATALYST: A study of the efficacy and safety of bardoxolone methyl in patients with connective tissue disease-associated pulmonary arterial hypertension (Phase III) - ES (Completed)

Reata Pharmaceuticals

Plus de détails

ETATS-UNIS

Texas
IRVING

CARDINAL: A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Alport Syndrome - ES (terminated)

Reata Pharmaceuticals

Plus de détails